Article
Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system
21 Dec 2022
Abstract excerpt
The oral protease inhibitor nirmatrelvir is of key importance for prevention of severe coronavirus disease 2019 (COVID-19). To facilitate resistance monitoring, we studied severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) escape from nirmatrelvir in cell culture. Resistant variants harbored combinations of substitutions in the SARS-CoV-2 main protease (Mpro). Reverse genetics revealed that E166V and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
